Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment

Adjuvant therapy recommendations for endometrial cancer were historically based on the individual patient’s risk of disease recurrence using clinicopathologic factors such as age, stage, histologic subtype, tumor grade, and lymphovascular space invasion. Despite the excellent prognosis for early sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Nero, Camilla, Ciccarone, Francesca, Pietragalla, Antonella, Duranti, Simona, Daniele, Gennaro, Scambia, Giovanni, Lorusso, Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442623/
https://www.ncbi.nlm.nih.gov/pubmed/34540651
http://dx.doi.org/10.3389/fonc.2021.612450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442623/
https://www.ncbi.nlm.nih.gov/pubmed/34540651
http://dx.doi.org/10.3389/fonc.2021.612450

Ejemplares similares